Selected research
Market Structure
Global Pharmaceutical Laminated Tubes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Laminated Tubes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharmaceutical Laminated Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Laminated Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Laminated Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Laminated Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Laminated Tubes include Amcor, Neelam Global, ALLTUB, Zálesí Packaging, EPL, Huhtamaki, Hoffmann Neopac, Montebello Packaging and Foshan Nanhai Xinbaode Plastics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharmaceutical Laminated Tubes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Laminated Tubes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Laminated Tubes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Laminated Tubes market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Laminated Tubes Segment by Company
Amcor
Neelam Global
ALLTUB
Zálesí Packaging
EPL
Huhtamaki
Hoffmann Neopac
Montebello Packaging
Foshan Nanhai Xinbaode Plastics
Shunfeng Pharmaceutical Packaging Materials
Anyang Hongcheng Packaging
Anyang Huaqiang Packaging
Hebei Antai Plastic Packaging Products
Zhongshan New Hua Mei Industry
Pharmaceutical Laminated Tubes Segment by Type
ABL (Aluminium Barrier Layer)
PBL (Plastic Barrier Layer)
Pharmaceutical Laminated Tubes Segment by Application
Dermatological Preparations
Ophthalmic Preparations
Oral and Throat Preparations
Other
Pharmaceutical Laminated Tubes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Laminated Tubes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Laminated Tubes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Laminated Tubes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical Laminated Tubes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Laminated Tubes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Laminated Tubes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharmaceutical Laminated Tubes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ABL (Aluminium Barrier Layer)
- PBL (Plastic Barrier Layer)
Applications
- Dermatological Preparations
- Ophthalmic Preparations
- Oral and Throat Preparations
- Other
Companies covered
- Amcor
- Neelam Global
- ALLTUB
- Zálesí Packaging
- EPL
- Huhtamaki
- Hoffmann Neopac
- Montebello Packaging
- Foshan Nanhai Xinbaode Plastics
- Shunfeng Pharmaceutical Packaging Materials
- Anyang Hongcheng Packaging
- Anyang Huaqiang Packaging
- Hebei Antai Plastic Packaging Products
- Zhongshan New Hua Mei Industry
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Laminated Tubes Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Laminated Tubes Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharmaceutical Laminated Tubes Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharmaceutical Laminated Tubes Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharmaceutical Laminated Tubes Market Dynamics
- 2.1 Pharmaceutical Laminated Tubes Industry Trends
- 2.2 Pharmaceutical Laminated Tubes Industry Drivers
- 2.3 Pharmaceutical Laminated Tubes Industry Opportunities and Challenges
- 2.4 Pharmaceutical Laminated Tubes Industry Restraints
3 Pharmaceutical Laminated Tubes Market by Manufacturers
- 3.1 Global Pharmaceutical Laminated Tubes Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Laminated Tubes Sales by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Laminated Tubes Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Laminated Tubes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Laminated Tubes Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Laminated Tubes Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Laminated Tubes Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Laminated Tubes Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Laminated Tubes Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharmaceutical Laminated Tubes Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Laminated Tubes Market by Type
- 4.1 Pharmaceutical Laminated Tubes Type Introduction
- 4.1.1 ABL (Aluminium Barrier Layer)
- 4.1.2 PBL (Plastic Barrier Layer)
- 4.2 Global Pharmaceutical Laminated Tubes Sales by Type
- 4.2.1 Global Pharmaceutical Laminated Tubes Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Laminated Tubes Sales by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Laminated Tubes Sales Market Share by Type (2021-2032)
- 4.3 Global Pharmaceutical Laminated Tubes Revenue by Type
- 4.3.1 Global Pharmaceutical Laminated Tubes Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharmaceutical Laminated Tubes Revenue by Type (2021-2032)
- 4.3.3 Global Pharmaceutical Laminated Tubes Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Laminated Tubes Market by Application
- 5.1 Pharmaceutical Laminated Tubes Application Introduction
- 5.1.1 Dermatological Preparations
- 5.1.2 Ophthalmic Preparations
- 5.1.3 Oral and Throat Preparations
- 5.1.4 Other
- 5.2 Global Pharmaceutical Laminated Tubes Sales by Application
- 5.2.1 Global Pharmaceutical Laminated Tubes Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Laminated Tubes Sales by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Laminated Tubes Sales Market Share by Application (2021-2032)
- 5.3 Global Pharmaceutical Laminated Tubes Revenue by Application
- 5.3.1 Global Pharmaceutical Laminated Tubes Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharmaceutical Laminated Tubes Revenue by Application (2021-2032)
- 5.3.3 Global Pharmaceutical Laminated Tubes Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Laminated Tubes Sales by Region
- 6.1 Global Pharmaceutical Laminated Tubes Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Laminated Tubes Sales by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Laminated Tubes Sales by Region (2021-2026)
- 6.2.2 Global Pharmaceutical Laminated Tubes Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Laminated Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Laminated Tubes Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Laminated Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Laminated Tubes Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Laminated Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Laminated Tubes Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharmaceutical Laminated Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharmaceutical Laminated Tubes Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharmaceutical Laminated Tubes Revenue by Region
- 7.1 Global Pharmaceutical Laminated Tubes Revenue by Region
- 7.1.1 Global Pharmaceutical Laminated Tubes Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharmaceutical Laminated Tubes Revenue by Region (2021-2026)
- 7.1.3 Global Pharmaceutical Laminated Tubes Revenue by Region (2027-2032)
- 7.1.4 Global Pharmaceutical Laminated Tubes Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharmaceutical Laminated Tubes Revenue (2021-2032)
- 7.2.2 North America Pharmaceutical Laminated Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharmaceutical Laminated Tubes Revenue (2021-2032)
- 7.3.2 Europe Pharmaceutical Laminated Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharmaceutical Laminated Tubes Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharmaceutical Laminated Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharmaceutical Laminated Tubes Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharmaceutical Laminated Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Amcor
- 8.1.1 Amcor Company Information
- 8.1.2 Amcor Business Overview
- 8.1.3 Amcor Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Amcor Pharmaceutical Laminated Tubes Product Portfolio
- 8.1.5 Amcor Recent Developments
- 8.2 Neelam Global
- 8.2.1 Neelam Global Company Information
- 8.2.2 Neelam Global Business Overview
- 8.2.3 Neelam Global Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Neelam Global Pharmaceutical Laminated Tubes Product Portfolio
- 8.2.5 Neelam Global Recent Developments
- 8.3 ALLTUB
- 8.3.1 ALLTUB Company Information
- 8.3.2 ALLTUB Business Overview
- 8.3.3 ALLTUB Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ALLTUB Pharmaceutical Laminated Tubes Product Portfolio
- 8.3.5 ALLTUB Recent Developments
- 8.4 Zálesí Packaging
- 8.4.1 Zálesí Packaging Company Information
- 8.4.2 Zálesí Packaging Business Overview
- 8.4.3 Zálesí Packaging Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Zálesí Packaging Pharmaceutical Laminated Tubes Product Portfolio
- 8.4.5 Zálesí Packaging Recent Developments
- 8.5 EPL
- 8.5.1 EPL Company Information
- 8.5.2 EPL Business Overview
- 8.5.3 EPL Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 EPL Pharmaceutical Laminated Tubes Product Portfolio
- 8.5.5 EPL Recent Developments
- 8.6 Huhtamaki
- 8.6.1 Huhtamaki Company Information
- 8.6.2 Huhtamaki Business Overview
- 8.6.3 Huhtamaki Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Huhtamaki Pharmaceutical Laminated Tubes Product Portfolio
- 8.6.5 Huhtamaki Recent Developments
- 8.7 Hoffmann Neopac
- 8.7.1 Hoffmann Neopac Company Information
- 8.7.2 Hoffmann Neopac Business Overview
- 8.7.3 Hoffmann Neopac Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hoffmann Neopac Pharmaceutical Laminated Tubes Product Portfolio
- 8.7.5 Hoffmann Neopac Recent Developments
- 8.8 Montebello Packaging
- 8.8.1 Montebello Packaging Company Information
- 8.8.2 Montebello Packaging Business Overview
- 8.8.3 Montebello Packaging Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Montebello Packaging Pharmaceutical Laminated Tubes Product Portfolio
- 8.8.5 Montebello Packaging Recent Developments
- 8.9 Foshan Nanhai Xinbaode Plastics
- 8.9.1 Foshan Nanhai Xinbaode Plastics Company Information
- 8.9.2 Foshan Nanhai Xinbaode Plastics Business Overview
- 8.9.3 Foshan Nanhai Xinbaode Plastics Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Foshan Nanhai Xinbaode Plastics Pharmaceutical Laminated Tubes Product Portfolio
- 8.9.5 Foshan Nanhai Xinbaode Plastics Recent Developments
- 8.10 Shunfeng Pharmaceutical Packaging Materials
- 8.10.1 Shunfeng Pharmaceutical Packaging Materials Company Information
- 8.10.2 Shunfeng Pharmaceutical Packaging Materials Business Overview
- 8.10.3 Shunfeng Pharmaceutical Packaging Materials Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Shunfeng Pharmaceutical Packaging Materials Pharmaceutical Laminated Tubes Product Portfolio
- 8.10.5 Shunfeng Pharmaceutical Packaging Materials Recent Developments
- 8.11 Anyang Hongcheng Packaging
- 8.11.1 Anyang Hongcheng Packaging Company Information
- 8.11.2 Anyang Hongcheng Packaging Business Overview
- 8.11.3 Anyang Hongcheng Packaging Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Anyang Hongcheng Packaging Pharmaceutical Laminated Tubes Product Portfolio
- 8.11.5 Anyang Hongcheng Packaging Recent Developments
- 8.12 Anyang Huaqiang Packaging
- 8.12.1 Anyang Huaqiang Packaging Company Information
- 8.12.2 Anyang Huaqiang Packaging Business Overview
- 8.12.3 Anyang Huaqiang Packaging Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Anyang Huaqiang Packaging Pharmaceutical Laminated Tubes Product Portfolio
- 8.12.5 Anyang Huaqiang Packaging Recent Developments
- 8.13 Hebei Antai Plastic Packaging Products
- 8.13.1 Hebei Antai Plastic Packaging Products Company Information
- 8.13.2 Hebei Antai Plastic Packaging Products Business Overview
- 8.13.3 Hebei Antai Plastic Packaging Products Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Hebei Antai Plastic Packaging Products Pharmaceutical Laminated Tubes Product Portfolio
- 8.13.5 Hebei Antai Plastic Packaging Products Recent Developments
- 8.14 Zhongshan New Hua Mei Industry
- 8.14.1 Zhongshan New Hua Mei Industry Company Information
- 8.14.2 Zhongshan New Hua Mei Industry Business Overview
- 8.14.3 Zhongshan New Hua Mei Industry Pharmaceutical Laminated Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Zhongshan New Hua Mei Industry Pharmaceutical Laminated Tubes Product Portfolio
- 8.14.5 Zhongshan New Hua Mei Industry Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharmaceutical Laminated Tubes Value Chain Analysis
- 9.1.1 Pharmaceutical Laminated Tubes Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharmaceutical Laminated Tubes Production Mode & Process
- 9.2 Pharmaceutical Laminated Tubes Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Laminated Tubes Distributors
- 9.2.3 Pharmaceutical Laminated Tubes Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst